A New Technique for Sacrospinous-Sacrotuberous Fixation for the Treatment of Uterovaginal and Vaginal Vault Prolapse

July 7, 2020 updated by: Mohamed S Sweed, MD, Ain Shams University

A New Technique for Sacrospinous-Sacrotuberous Fixation for the Treatment of Uterovaginal and Vaginal Vault Prolapse: A Randomized Controlled Trial

This prospective interventional randomized controlled trial is conducted to compare a new technique for Sacrospinous-Sacrotuberous fixation with the traditional sacrospinous ligament fixation technique for treatment of uterovaginal and vaginal vault prolapse.

Study Overview

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt
        • Ain shams university maternity hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  1. Age from 40 to 60 years.
  2. POP Q stage III & IV
  3. Uterovaginal prolapse.
  4. Vaginal vault prolapse.
  5. BMI >35.

Exclusion Criteria:

  1. Age > 40 years or < 60 years.
  2. POP Q stage I or II.
  3. BMI < 35.
  4. Previous repair of uterovaginal or vaginal vault prolapse.
  5. Comorbidity with Stress Urinary Incontinence.
  6. Presence of persistent risk factor increasing intra-abdominal pressure e.g. chronic chest conditions.
  7. Any significant comorbidity or psychiatric disorder that would compromise patient's consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Modified technique for Sacrospinous-Sacrotuberous Fixation
Sacrospinous-Sacrotuberous fixation
Active Comparator: Conventional technique for Sacrospinous-Sacrotuberous Fixation
Modified technique for Sacrospinous-Sacrotuberous Fixation
Sacrospinous-Sacrotuberous fixation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of participants with recurrence of uterovaginal and vaginal vault prolapse
Time Frame: 1 year
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
operative time
Time Frame: intraoperative
intraoperative
blood loss
Time Frame: intraoperative
intraoperative
Injury to surrounding structures
Time Frame: intraoperative
Number of participants that experience injury of important surrounding structure intraoperative
intraoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 21, 2018

Primary Completion (Actual)

May 1, 2020

Study Completion (Actual)

May 1, 2020

Study Registration Dates

First Submitted

March 21, 2018

First Submitted That Met QC Criteria

April 2, 2018

First Posted (Actual)

April 4, 2018

Study Record Updates

Last Update Posted (Actual)

July 8, 2020

Last Update Submitted That Met QC Criteria

July 7, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • AS1729

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Uterovaginal and Vaginal Vault Prolapse

Clinical Trials on Sacrospinous-Sacrotuberous fixation

3
Subscribe